Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

90.55 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 90.55
Bid (Size) 86.50 (1)
Ask (Size) 91.00 (1)
Prev. Close 90.55
Today's Range 90.55 - 90.55
52wk Range 79.64 - 98.52
Shares Outstanding N/A
Dividend Yield 3.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel ... 
Tags News LMDX General
From Benzinga

Performance

YTD
+3.05%
+3.05%
1 Month
+6.09%
+6.09%
3 Month
+9.97%
+9.97%
6 Month
-0.08%
-0.08%
1 Year
-6.35%
-6.35%

More News

Read More
7 Best Long-Term Stocks to Buy and Hold for the Next Decade
Tags Market News NASDAQ:COIN,NASDAQ:AMAT,NYSE:MO,NASDAQ:INTC,NYSE:PFE,NYSE:NVS,NASDAQ:STNE AMAT
From InvestorPlace
3 Top Biotech Stocks to Buy Right Now
Tags Recent Press Releases NVS GSK
From Motley Fool
Where Will Biogen Be in 5 Years?
Tags RHHBY BIIB SAGE
From Motley Fool
Novartis To In-License COVID-19 Treatment From Molecular Partners, After Encouraging Mid-Stage Data
Tags Small Cap Briefs Contracts
From Benzinga
Why Molecular Partners Stock Crushed the Market Today
Tags Market News NVS MOLN
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Tags Penny Stocks FDA ALNY
From Benzinga
Novartis to seek FDA approval for COVID-19 treatment after positive data
Tags CH:NOVN MOLN NVS
From MarketWatch
Pfizer Snagged Another Approval for This Immunology Drug
Tags Market News ABBV LLY
From Motley Fool
Markets Inching Up
Tags Stocks / Equities Market News
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.